David Grainger
David graduated with a first class degree from Cambridge University in 1989 before completing his PhD at Cambridge in 1992. He is currently directing an internationally recognized group of researchers in the Department of Medicine at Cambridge University in the field of inflammation, with a particular interest in cardiovascular disease.
His research has been published in a range of leading peer-reviewed journals including Science, Nature and Nature Medicine, and he sits on the editorial board of a number of journals as well as reviewing grant applications for major funding bodies in both Europe and the US. In addition, he sits on the scientific advisory board of a number of biotechnology companies, as well as running a successful consultancy business, TCP Innovations Ltd. With over 75 scientific publications, David is also an inventor on more than 120 patents and patent applications.
Between 2002 and 2006, David was the Director of the Translational Research Unit, of the Papworth Hospital NHS Foundation Trust. The Translational Research Unit comprises a dedicated clinical trials unit based at the UK’s premier cardiothoracic hospital. Under David's direction, the unit performed multiple large (1,000+ patient) clinical trials, as well as a number of smaller clinical research studies.